Peter Holst

Company: Hervolution Therapeutics
Job title: CSO
Seminars:
Decoding Human Endogenous Retroviruses’ Role in Aging to Facilitate Therapeutic Targeting 4:45 pm
Understanding HERV biology to characterize reactivation in disease Determining HERV dysregulation in disease to understand immune interactions Modifying HERVs to deactivate inherent immune suppression and yield immunogenic antigensRead more
day: Day 1